Short Information | Organon & Co. (NYSE:OGN)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 160,637 |
Total Actual Volume | 27,473,266 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 8,032 |
Average Short Percentage | 0.69% |
Is there a OGN Short Squeeze or Breakout about to happen?
See the OGN Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $21.14 | $21.54 | $21.56 | $20.67 | 1,292,124 | 2,032 | 0.16% |
07-19-2024 | $20.94 | $20.98 | $21.18 | $20.86 | 1,126,580 | 2,325 | 0.21% |
07-18-2024 | $21.03 | $20.97 | $21.49 | $20.87 | 1,154,055 | 4,051 | 0.35% |
07-17-2024 | $20.6 | $21.16 | $21.43 | $20.55 | 1,809,180 | 13,666 | 0.76% |
07-16-2024 | $20.84 | $20.81 | $21.0498 | $20.635 | 1,361,767 | 2,068 | 0.15% |
07-15-2024 | $21.36 | $20.73 | $21.39 | $20.72 | 1,024,507 | 3,112 | 0.3% |
07-12-2024 | $21.02 | $21.3 | $21.44 | $20.82 | 1,962,256 | 4,429 | 0.23% |
07-11-2024 | $20.24 | $20.88 | $20.99 | $20.15 | 1,723,333 | 1,177 | 0.07% |
07-10-2024 | $19.93 | $19.92 | $20.05 | $19.34 | 1,938,017 | 1,603 | 0.08% |
07-09-2024 | $20.14 | $19.93 | $20.292 | $19.835 | 1,785,829 | 10,011 | 0.56% |
07-08-2024 | $20.31 | $20.14 | $20.46 | $20.12 | 1,074,133 | 90,774 | 8.45% |
07-05-2024 | $20.25 | $20.11 | $20.31 | $19.94 | 1,887,381 | 3,113 | 0.16% |
07-03-2024 | $20.18 | $20.31 | $20.55 | $20.12 | 890,360 | 1,233 | 0.14% |
07-02-2024 | $20.16 | $20.12 | $20.38 | $20.05 | 913,768 | 2,411 | 0.26% |
07-01-2024 | $20.82 | $20.31 | $21.01 | $20.17 | 1,483,376 | 3,404 | 0.23% |
06-28-2024 | $20.76 | $20.7 | $21.03 | $20.515 | 2,030,415 | 721 | 0.04% |
06-27-2024 | $20.59 | $20.59 | $20.71 | $20.3802 | 873,670 | 5,197 | 0.59% |
06-26-2024 | $20.61 | $20.63 | $20.71 | $20.405 | 869,724 | 1,417 | 0.16% |
06-25-2024 | $21.13 | $20.79 | $21.19 | $20.79 | 845,666 | 5,380 | 0.64% |
06-24-2024 | $20.95 | $21.12 | $21.4399 | $20.9 | 1,427,125 | 2,513 | 0.18% |
News, Short Squeeze, Breakout and More Instantly...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational Prolia ® and Xgeva ® (denosumab) biosimilar. Denosumab has been a...